Company intelligence / Profile preview

MKM Partners

Stamford, Connecticut, United Statesrothmkm.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

MKM Partners was an institutional equity research, sales, and trading firm headquartered in Stamford, Connecticut. The firm provided fundamental research, macro-economic analysis, and execution services to institutional investors across various sectors, including healthcare and life sciences. In early 2023, MKM Partners was acquired by Roth Capital Partners, resulting in the formation of Roth MKM. The company operates as a financial services provider rather than a biotechnology or pharmaceutical developer. It was widely recognized for its technical analysis and corporate access events.

Industry: Investors

Beyond the preview

Go deeper on MKM Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MKM Partners.

Explore the full profile